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ABSTRACT
Despite gains in controlling mortality relating to diarrhoeal disease, the burden of disease remains unac-
ceptably high. To refocus health research to target disease-burden reduction as the goal of research in child 
health, the Child Health and Nutrition Research Initiative developed a systematic strategy to rank health 
research options. This priority-setting exercise included listing of 46 competitive research options in diar-
rhoeal disease and their critical and quantitative appraisal by 10 experts based on five criteria for research 
that reflect the ability of the research to be translated into interventions and achieved disease-burden re-
duction. These criteria included the answerability of the research questions; the efficacy and effectiveness 
of the intervention resulting from the research; the maximal potential for disease-burden reduction of the 
interventions derived from the research; the affordability, deliverability, and sustainability of the intervention 
supported by the research; and the overall effect of the research-derived intervention on equity. Experts 
scored each research option independently to delineate the best investments for diarrhoeal disease control 
in the developing world to reduce the burden of disease by 2015. Priority scores obtained for health policy 
and systems research obtained eight of the top 10 rankings in overall scores, indicating that current invest-
ments in health research are significantly different from those estimated to be the most effective in reduc-
ing the global burden of diarrhoeal disease by 2015.
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INTRODUCTION
Diarrhoeal disease causes an estimated 1.8 million 
deaths per year (1). Despite evidence of reduction 
in mortality over the last 50 years (2,3), diarrhoeal 
disease continues to be a major killer of children 
aged less than five years and a principal cause of 
morbidity for most impoverished children of the 
world. It is well-known that most of these deaths 
are preventable with existing disease- control strat-
egies (4).
Although there are numerous causes for the lack of 
greater progress in the control of diarrhoeal diseas-
es, it is clear that our investments in related research 
over the last 20 years have not had the greatest at-
tainable impact. It is now increasingly recognized 
that research priorities do not optimally address the 
needs of children in developing countries (5,6). Set-
ting research priorities is clearly a challenging and 
imperfect process that relies on the best data avail-
able and the knowledge of experts in the field to 
fill in knowledge gaps. Clearly, data regarding the 
number and cause of deaths and the coverage of 
interventions are limited and imperfect. How to 
integrate available data with expert opinion is an 
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evolving area. Classically, they were derived from 
expert group meetings and, more recently, Del-
phi exercises have been employed as an improved 
strategy to incorporate expert opinion in decision-
making processes. Cost-effectiveness analyses have 
been used for prioritizing among health interven-
tions but have not been systematically used for 
determining the most promising research. In any 
case, cost-effectiveness analysis would have limited 
usefulness without a critical assessment of the like-
lihood that investments in research would result 
in reduction in the burden of disease. The Child 
Health and Nutrition Research Initiative (CHNRI) 
was founded to encourage and support research on 
the important child health problems in low- and 
middle-income countries. The CHNRI developed a 
structured process that was designed to measure the 
likelihood that funding-specific research questions 
would be successful in reducing child morbidity 
and mortality. This novel methodology was used 
here for assessing the priority for funding particular 
avenues of research to address the burden of disease 
caused by childhood diarrhoea (7,8).
MATERIALS AND METHODS
Selection of group members and research 
options
As part of a larger exercise of assessing research 
priorities for major child health conditions, the 
CHNRI decided that the exercise should consider 
research for burden of reduction of diarrhoeal dis-
ease by 2015 among children aged less than five 
years. Since the currently-accepted disease-burden 
measure is the disability-adjusted life-year (DALY), 
which incorporated both mortality and morbidi- 
ty components of disease, our scoring exercise in-
cluded both mortality and morbidity components. 
However, due to the current thinking on disease 
weighting, most burden of diarrhoeal disease is re-
lated to mortality rather than morbidity, and scor-
ers were asked to respect this current thinking. The 
CHNRI Secretariat selected two group members (CL 
and MK). These two members defined the list of 
research options in communication with IR, based 
on a systematic framework for listing research op-
tions relating to a single disease developed by the 
CHNRI (7,8). This systematic approach enables 
comprehensive listing and equal treatment of re-
search options in different broad research domains: 
epidemiologic research, health policy and systems 
research (HSPR), research intended to improve ex-
isting interventions, and research to develop new 
interventions. The list of research questions was 
intentionally limited to less than 50 to allow indi-
viduals to be able to complete the scoring process 
in a single day. These research options included 
different strategies in diarrhoeal disease control en-
compassing those aimed at improving water and 
sanitation infrastructure, those targeting health-
care-delivery strategies, those addressing nutrition-
al deficiencies, and research to evaluate novel di-
agnostics and vaccines. The research options were 
then categorized as either: (a) Health policy and 
systems research (HSPR) that aimed to improve the 
efficiency and coverage of known interventions; (b) 
Research that improved existing interventions by 
making them more affordable or deliverable; or (c) 
Research options to develop entirely new interven-
tions. Although a research option could encompass 
multiple different research questions, it was made 
sufficiently narrow in scope to be able to anticipate 
specific research project derivatives that could be 
evaluated by the scoring process. 
A further 17 experts were invited to participate, 
of whom eight completed and returned priority 
scores for a total group of scorers comprising 10 
individuals [Group of scorers: Shinjini Bhatnager, 
Zulfiqar A. Bhutta, Olivier Fontaine, Margaret Ko-
sek, Claudio F. Lanata, Dilip Mahalanabis, Moham-
med Abdus Salam, John D. Snyder, Cesar Victora, 
and Damian G. Walker].
These individuals were categorized as physicians 
with expertise in infectious diseases, gastroenterolo-
gists, public-health researchers specialized in pro-
grammatic issues, a health economist, and public-
health researchers in areas other than programme 
development and evaluation. Each one scored the 
individual research options independently using a 
five-component structured model developed by the 
CHNRI to evaluate health research. The five compo-
nents consist of the following: (a) likelihood that the 
research option can yield new knowledge in an ethi-
cal manner; (b) likelihood that the research findings 
will lead to efficacious and effective interventions; 
(c) likelihood that the intervention derived from the 
research would be affordable and deliverable to the 
population of interest; (d) most likely maximum 
burden of disease reduction that could be derived 
from interventions resulting from research within 
the option; and (e) likely impact that the derivates of 
the research will have on equity.
Scores were computed as percentage of maximal 
obtainable points for each of the major five com-
ponents being evaluated and then combined for an 
overall score. The scores outline both limitations 
and strengths of each research option. Each of the 
five intermediate scores reflect the likelihood that 
the research option will be answerable, that it will 
result in an effective intervention, that the result-
Kosek M et al.Research priorities for diarrhoeal disease
Volume 27 | Number 3 | June 2009 321
ing intervention will be deliverable, that the result-
ing intervention will increase equity, and an esti-
mation of the maximal disease-burden impact an 
intervention resulting from the research is foreseen 
to have. When added together, this overall score 
becomes a quantitative measure of the collective 
optimism that research in that area can have sub-
stantial impact prior to 2015. Although this system 
easily accommodates weighting of these five op-
tions by donors or regional agencies or other stake-
holders, we have presented the unweighted results. 
The process of scoring is presented in greater detail 
elsewhere (7-10).
RESULTS
The listing of research options yielded 46 options. 
Twenty-one research options were designed as 
health policy and systems research to increase the 
efficiency of interventions already in place, 10 
options addressed research to improve the afford-
ability and deliverability of known interventions, 
and 15 options were primary research to develop 
new interventions. The complete list of the 46 re-
search options is presented in Table 1. The ques-
tions guiding the scoring of the research options 
by each criteria are shown in Table 2. An excel file 
that facilitates the scoring exercise by providing a 
spreadsheet for the input of scores is available on-
line (http://www.icddrb.org/jhpn).
Criterion 1: Generating new knowledge
Priority scores for research options evaluated solely 
on the criterion of their ability to generate new 
knowledge ranged from 57.0% to 95.8%. The top 
five research options that were predicted to en-
counter minimal obstacles in their realization are 
listed in Table 3. The research option that received 
the highest score for this criterion was the conduc-
tion of cost-effectiveness studies of rotavirus vac-
cines in different epidemiologic contexts. The sec-
ond ranked research option by this criterion was 
effectiveness studies to evaluate the expanded use 
of low-osmolarity oral rehydration solution (ORS). 
Two research alternatives received equal scores to 
rank third. These options included health policy 
and systems research to improve the deliverability 
and cost of zinc treatment in diarrhoeal disease pro-
grammes and health policy and systems research to 
improve coverage of rotavirus vaccine in countries 
with the greatest burden of disease. Health policy 
and systems research to improve case management 
of moderate and severe cases of diarrhoeal illness 
by using standardized case management and the 
development of new antibiotics for the treatment 
of drug-resistant shigellosis tied for fourth place in 
the ranking. The fifth rank was occupied by two 
evenly-ranked options of health policy and services 
research to increase access to ORS envelops at all 
times to all children who need it and health policy 
and services research to increase the percentage of 
infants exclusively breastfed up to the age of six 
months.
Low scoring research options in this category were 
predominated by enteric vaccines that are currently 
in early stages of development as these are unlikely 
to yield clinical trials demonstrating efficacy prior 
to 2015. Scores for Campylobacter, enteropathogen-
ic Escherichia coli, Entamoeba histolytica, and noro-
virus all obtained scores for answerability ranging 
between 57% and 68%.
Criterion 2: Efficacy and effectiveness
The priority scoring of research options based solely 
on their predicted potential to lead to (or improve) 
efficacious and effective interventions yielded 
scores ranging from 32.0% to 97.9% (Table 4). The 
top research option when judged by this criterion 
was the study of cost-effectiveness of rotavirus vac-
cine in different epidemiologic contexts. The sec-
ond-ranking research option was health policy and 
services research to increase the access to ORS for 
all children who may need it. Effectiveness, health 
policy and services research, and educational/be-
havioural modification studies to improve the de-
liverability and cost of zinc treatment in diarrhoea-
control programmes in several regions of the world 
with different epidemiologic profiles occupied the 
third rank. Tied for the fourth ranking was research 
to generate new knowledge (mostly effectiveness 
studies) to increase use of low-osmolarity ORS and 
health systems research to increase the coverage of 
measles vaccine. The fifth-ranking research option 
in terms of efficacy and effectiveness was health 
policy and systems research to improve the quality 
of care of moderate/severe diarrhoea cases through 
standardized case management.
Research options that received low scores in this 
area were diverse and included research relat-
ing to fly control, the improved storage of wean-
ing foods, and the development of interventions 
meant to curb bacterial contamination of crops.
Criterion 3: Sustainability and deliverability
Priority scores for options evaluated based on sus-
tainability and deliverability alone had the widest 
variation in obtained scores of the five criteria with 
scores ranging from 9% to 90%. The highest score 
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Table 1. List of 46 research options scored by diarrhoeal disease experts
Research option
RO1  : Health policy and systems research (HPSR) to increase access to ORS packets at all times in 
all sites for all children who may need it
RO2  : Research to generate new knowledge (mostly effectiveness studies) to increase the use of 
low-osmolarity ORS
RO3  : Health policy, systems, and education/behaviour modification research to increase the 
percentage of infants with exclusive breastfeeding at <6 month of age
RO4  : Health policy, systems, and education/behaviour modification research to increase the per-
centage of infants and children, aged less than 2 years, who are breastfed
RO5  : Health system research to increase the coverage of measles vaccine
RO6  : HPSR to improve the coverage of rotavirus vaccine in countries with the greatest needs 
RO7  : Systems and education/behaviour modification research to increase water consumed per 
person per day
RO8  : System research to measure the effectiveness of piped water systems on diarrhoea if they 
are installed at the community vs in the home
RO9  : System research to measure the effectiveness of piped water systems on diarrhoea if they 
are installed so as to provide intermittent vs 24-hour availability
RO10 : Systems and education/behaviour modification research to increase the coverage of sewage systems 
RO11: Systems and education/behaviour modification research to increase the prevalence of ef-
fective latrines 
RO12 : Health policy, systems, and education/behaviour modification research to increase the proportion 
of women and children washing their hands effectively to improve hand-washing promotion
RO13 : Education/behaviour modification research to increase the energy density of weaning foods at 
the household level (in areas with food availability)
RO14: HPSR to allow that all mothers with a child with diarrhoea will know how to recognize danger-
signs for timely referral/self-referral of severe cases
RO15: HPSR to improve the quality of care of moderate/severe diarrhoea cases through standard-
ized case management
RO16: HPSR to improve prescription of appropriate antibiotics for dysentery
RO17 : Efficacy/effectiveness studies of interventions of behaviour modification to reduce baby bottle-use
RO18: Education/behaviour modification research to increase the use of refrigerators for storage 
of weaning foods
RO19: Efficacy/effectiveness studies and education/behaviour modification research to increase 
consumption of Lactobacillus GG probiotic 
RO20: Efficacy/effectiveness studies of interventions of behaviour modification to increase pot-
ties-use/improved faece-disposal practices 
RO21: HPSR to generate new knowledge to increase the coverage of vitamin A supplementation 
RO22: System and community research to reduce costs/improve deliverability and increase the 
coverage of piped water systems 
RO23: Effectiveness, costs, sustainability, system and behavioural modification/cultural research 
to increase the use of point-of-use water disinfection: implementation of point-of-use treat-
ment and water-storage practices
RO24: Research to develop new ways of sewage-treatment systems that will make them affordable 
to developing countries
RO25: Research to improve the deliverability, measure effectiveness, and determine the sustainability of 
fly-control interventions
RO26: Effectiveness studies and studies that will reduce the cost/improve the deliverability of 
cholera vaccines in high-burden countries 
RO27: Cash-transfer programmes to improve diet quality and nutrition in poor areas
RO28: Policy, systems, and education/behaviour modification research to improve current strategies 
aiming at improving the quality of diet of family in areas with low access to good diets
Contd.
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Table 1—Contd.
RO29: Effectiveness, HPSR, and educational/behaviour modification studies to improve the de-
liverability/cost of zinc treatment in diarrhoea-control programmes in several regions of 
the world with different epidemiological profiles
RO30: Efficacy, effectiveness and cost studies that will increase the use of zinc food-fortification 
programmes in developing countries
RO31: Cost-effectiveness studies of rotavirus vaccine in different epidemiologic contexts
RO32: Develop norovirus vaccines
RO33: Develop Shigella vaccines
RO34: Develop ETEC vaccines
RO35: Develop Campylobacter vaccines
RO36: Develop EPEC vaccines
RO37: Develop Helicobacter pylori vaccines
RO38: Develop vaccines for Entamoeba histolytica
RO39: Develop new measles vaccines that will be heat-stable and able to immunize newborns
RO40: Solar ovens to keep weaning foods above >50 0C for a day
RO41: Low cost, no electrical/no fuel consuming refrigerators to storage food at the household level
RO42: New antibiotics for drug-resistant Shigella
RO43: New antibiotics for drug-resistant cholera
RO44: Develop interventions that will reduce bacterial contamination of crops irrigated with 
contaminated water in developing countries
RO45: Further development of antisecretory agents in the management of paediatric diarrhoea
RO46: Develop the technology to deliver zinc to children using prolong dosing intervals
EPEC=Enteropathogenic Escherichia coli; ETEC=Enterotoxigenic Escherichia coli; ORS=Oral rehy-
dration solution; RO=Research option        
in terms of sustainability and deliverability was 
given to effectiveness studies to increase the use 
of low-osmolarity ORS which obtained a priority 
score of 90% (Table 5). The second ranking was 
to studies relating to the uptake and evaluation of 
zinc in diarrhea-control programmes in the dif-
ferent epidemiologic contexts. The third ranking 
was shared by research options for health policy 
and systems research to improve the prescription 
of appropriate antibiotics for dysentery and to in-
crease the coverage of vitamin A supplementation. 
The evaluation of the cost-effectiveness of rotavirus 
vaccine in the different epidemiologic contexts and 
health policy and systems research to improve the 
quality of care of moderate and severe diarrhoea 
cases through standardized case management were 
ranked fourth. The fifth-ranking option was health 
policy, systems and education and behavioural 
modification research to increase the proportion 
of women and children washing their hands effec-
tively.
Research options scoring poorly in deliverability 
and sustainability included options to increase the 
use of refrigerators for the storage of weaning foods, 
cash-transfer programmes to improve the quality 
of diet and nutrition in poor areas, and vaccines for 
E. histolytica and Camplylobacter.
Criterion 4: Maximal potential for disease- 
burden reduction
Priority scores to judge the maximum potential for 
disease-burden reduction ranged from 8% to 79% 
(Table 6). The top two scoring research options re-
lated to use of rotavirus vaccine. The top scoring 
research option achieved a priority score of 79.2% 
and was aimed at evaluating the cost-effectiveness 
of rotavirus vaccination in the different epidemio- 
logic contexts while health policy and systems re-
search to improve the coverage of rotavirus vacci-
nation in countries with the greatest need had a 
76.7% priority score. Health policy and services re-
search to increase access to ORS envelops received 
the third-ranking position and was followed in the 
ranking by health policy and services research to 
improve the deliverability and cost of zinc treat-
ment in diarrhoea-control programmes in several 
regions of the world with different epidemiologic 
profiles. The fifth-ranking option was health policy 
and systems research to train mothers in the recog-
nition of danger signs for the timely self-referral of 
severe cases of diarrhoea.
Low scores in maximal potential for disease-bur-
den reduction were obtained by research options 
relating to fly-control interventions, effectiveness, 
and deliverability of cholera vaccine, and efficacy 
and effectiveness studies relating to use of probiotic 
Lactobacillus GG.
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Table 4. Top 5 options for efficacy/efficaciousness (Criterion 2)
Rank Category Research options Score (%)
1 3 RO31: Cost-effectiveness studies of rotavirus vaccine in different 
epidemiologic contexts 97.9
2 2 RO1  : HPSR to increase access to ORS packets at all times in all 
sites for all children who may  need it 93.3
3 3 RO29: Effectiveness, HPSR, and educational/behaviour modification 
studies to improve the deliverability/cost of zinc treatment 
in diarrhoea-control programmes in several regions of the 
world with different epidemiological profiles 90.7
4 2 RO2  : Research to generate new knowledge (mostly effectiveness 
studies) to increase use of low-osmolarity ORS 86.7
4
2 RO5  : Health-systems research to increase the coverage of mea-
sles vaccine 86.7
5 2 RO15 : HPSR to improve the quality of care for moderate and severe 
diarrhoea cases through standardized case management 85.4
HPSR=Health policy and systems research; ORS=Oral rehydration solution; RO=Research option
Table 5. Top 5 options for sustainability and deliverability (Criterion 3)
Rank Category Research option Score (%)
1 2 RO2 : Research to generate new knowledge (mostly effectiveness 
studies) to increase the use of low-osmolarity ORS 90.0
2 3
RO29: Effectiveness, HPSR, and educational/behaviour modifi-
cation studies to improve the deliverability/cost of zinc 
treatment in diarrhoea-control programmes in several 
regions of the world with different epidemiological pro-
files
88.9
3 2 RO16: HPSR to improve prescription of appropriate antibiotics 
for dysentery
85.2
3 2 RO21: HPSR to generate new knowledge to increase the cover-
age of vitamin A supplementation (to reduce severity of 
diarrhoea and improve mortality)
85.2
4 3 RO31: Cost-effectiveness of rotavirus vaccine in different epide-
miologic contexts
83.3
4 2 RO15: HPSR to improve the quality of care for moderate and severe 
diarrhoea cases through standardized case management 83.3
5 2
RO12: Health policy, systems, and education/behaviour modifi-
cation research to increase the proportion of women and 
children washing their hands effectively 77.8
HPSR=Health policy and systems research; ORS=Oral rehydration solution; RO=Research option
Criterion 5: Equity
The scores for equity were the highest of any of the 
criteria and ranged from 43.0% to 98.3%. All five 
top options received priority scores greater than 
90% (Table 7). The top score was given to health 
systems research to increase the coverage of mea-
sles vaccine. The second-ranking research option 
was policy, systems, and education and behaviour 
modification research to improve current strategies 
aiming at improving the quality of diet of families 
in areas with low access to good diets. Systems and 
education and behavioural modification research to 
increase the prevalence of latrines was ranked third. 
Educational and behavioural modification research 
to increase the energy density of weaning foods at 
the household level in areas with food availability 
and systems and behavioural research to improve 
water consumed per person per day obtained equal 
scores to rank fourth among the selected research 
options. The fifth-ranking option was health policy 
and systems research to improve the quality of care 
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Table 6. Top 5 option for maximal potential to decrease disease burden (Criterion 4)
Rank Category Research option Score (%)
1 3 RO31: Cost-effectiveness of rotavirus vaccine in different 
epidemiologic contexts 79.2
2 2 R06   : HPSR to improve the coverage of rotavirus vaccine in 
countries with the greatest needs 76.7
3 2 RO1  : Health policy and systems research (HPSR) to increase 
access to ORS packets at all  times in all sites for all children 
who may need it 75.0
4 3 RO29: Effectiveness, HPSR, and educational/behaviour modifica-
tion studies to improve the deliverability/cost of zinc treat-
ment in diarrhoea-control programmes in several regions of 
the world with different epidemiological profiles 70.0
5 2 RO14: HPSR to allow that all mothers with a child with diarrhoea 
will know how to recognize danger-signs for timely refer-
ral/self-referral of severe cases 64.8
ORS=Oral rehydration solution; RO=Research option
Table 7. Top 5 options for equity (Criterion 5)
Rank Category Research option Score (%)
1 2
R05   : Health systems research to increase the coverage of mea-
sles vaccine 98.3
2 3
RO28: Policy, systems, and education/behaviour modification 
research to improve current strategies aiming at improv-
ing the quality of diet of family in areas with low access 
to good diets
96.7
3 2
RO11: Systems and education/behaviour modification research 
to increase the prevalence of effective latrines 93.3
4 2
RO13: Education/behaviour modification research to increase the 
energy density of weaning foods at the household level (in 
areas with food availability)
92.6
4 2
RO7  : Systems and education/behaviour modification research 
to improve water consumed per person per day 92.6
5 2
RO15: HPSR to the improve the quality of care for moderate and severe 
diarrhoea cases through standardized case management 90.7
HPSR=Health policy and systems research; RO=Research option 
of moderate and severe cases of diarrhoea through 
standardized case management.  
Low priority scores were obtained by research 
options to evaluate probiotic Lactobacillus GG, new 
antisecretory agents, and vaccines for E. histolytica, 
norovirus, and H. pylori.
Combined results
The overall priority scores that were assigned to re-
search options by computing unweighted means of 
the five intermediate scores ranged from 35.0% to 
85.2% (Table 8). The top scoring research items, 
overall, were predominantly (7/10) options that 
aimed at increasing the efficiency and coverage 
of interventions with known effectiveness. The 
research option receiving the highest priority score 
addressed effectiveness, health policy and services 
research to improve the deliverability and cost of 
zinc treatment in diarrhoea-control programmes 
in areas with different epidemiologic profiles. The 
second-ranking research option, which proposed 
conducting cost-effectiveness studies of rotavirus 
vaccine in different epidemiologic contexts received 
a priority score less than 1% lower than the top-
ranking option. Health policy and services research 
to increase access to ORS envelops and to improve 
the quality of care of moderate to severe cases of 
diarrhoea through standardized case management 
were ranked third and fourth respectively. Effective-
ness studies to increase the use of low-osmolarity 
ORS received the fifth-ranking priority score and 
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Table 8. Top 10 research options overall by five criteria
Rank Category Research option Score (%)
1 3 RO29 : Effectiveness, HPSR, and educational/behaviour modification 
studies to improve the deliverability/cost of zinc treatment in 
diarrhoea-control programmes in several regions of the world 
with different epidemiological profiles
 
85.2
2 3 RO31: Cost-effectiveness studies of rotavirus vaccine in different 
epidemiologic contexts
85.0
3 2 RO1  : Health policy and systems research (HPSR) to increase ac-
cess to ORS packets at all times in all sites for all children 
who may need it 81.6
4 2 RO15: HPSR to improve the quality of care for moderate/severe 
diarrhoea cases through  standardized case management 80.0
5 2 RO2  : Research to generate new knowledge (mostly effectiveness 
studies) to increase the use of low-osmolarity ORS 78.7
6 2 RO3  : Health policy, systems, and education/behaviour modi-
fication research to increase the percentage of infants with 
exclusive breastfeeding <6 months of age 77.4
7 2 RO5  : Health systems research to increase the coverage of mea-
sles vaccine 77.2
8
2 RO6  : HPSR to improve the coverage of rotavirus vaccine in 
countries with the greatest needs  75.0
9 2 RO14:  HPSR to allow that all mothers with a child with diarrhoea 
will know how to recognize danger-signs for time referral/
self-referral of severe cases 74.4
10 3 RO30: Efficacy, effectiveness and cost studies that will increase the use 
of zinc food-fortification  programmes in developing countries 73.0
HPSR=Health policy and systems research; ORS=Oral rehydration solution; RO=Research option
was followed closely by health policy, systems, and 
education and behavioural modification research 
to increase the percentage of infants exclusive-
ly breastfed for the first six months of life. Health 
systems research to increase the coverage of mea-
sles and rotavirus vaccines were ranked seventh 
and eighth respectively. Health policy and sys-
tems research to aid mothers in the recognition of 
danger-signs in cases of severe illness to improve 
self-referral ranked ninth, and the tenth priority 
ranking was assigned to efficacy, effectiveness and 
costing studies to evaluate the increased use of zinc-
fortification programmes in developing countries.
Vaccines
It is worth noting that the development of new 
vaccines for the improved control of the burden 
of diarrhoeal disease obtained low scores (Table 9). 
The highest-scoring vaccine was a measles vaccine 
that would be both heat-stable and effective when 
administered in the neonatal period. Research di-
rected towards obtaining this goal received a priori- 
ty score of 65.1%. The highest-scoring vaccine di-
rectly targeting an enteric organism was a vaccine 
against Shigella, which obtained a priority score of 
63.0%. Determining the cost-effectiveness of the 
currently-available cholera vaccine received a score 
of 61.7%.
There is little question that the group of scorers was 
not biased against vaccines as a whole or enteric 
vaccines. Two of the overall top 10 research options 
reflected research regarding the appropriate usage 
of rotavirus vaccine in different settings. In addi-
tion to this, health policy and service research to 
increase the coverage of the current measles vac-
cine was ranked seventh overall. In general, the 
existing vaccines with proven efficacy and poten-
tial for expanded access were scored higher than 
theoretical possibilities in vaccine research. Fur-
thermore, as the time set to expect the benefits of 
the research in terms of disease-burden reduction is 
2015, this timetable challenges vaccine research in 
areas in which knowledge on basic science regard-
ing the basis of acquired immunity or the global 
burden of disease is lacking. However, even with an 
efficacy of 95% in preventing mortality and 60% in 
preventing morbidity, few enteric pathogens cause 
an aetiologic fraction of morbidity and mortality 
of diarrhoeal disease large enough to compare with 
interventions that are independent of aetiology, 
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Table 9. Unweighted priority scores (%) for development of novel vaccines to diminish the burden of 
diarrhoeal disease
Vaccine
Criterion 1
(%)
Criterion 2
(%)
Criterion 3
(%)
Criterion 4
(%)
Criterion 5
(%)
Overall 
priority 
score (%)
New measles vac-
cines that will 
be heat-stable and 
able to immunize 
newborns
   
76.7 77.8 59.3 50.0 61.7 65.1
Shigella 83.3 83.3 44.4 35.2 68.5 63.0
ETEC 66.7 63.0 37.0 42.6 68.5 55.6
EPEC 63.3 43.8 25.0 37.0 68.5 47.5
Norovirus 68.3 54.2 31.3 29.2 44.4 45.5
Helicobacter pylori 63.3 41.7 24.1 14.8 42.6 37.3
Entameoba histolytica 63.3 43.8 14.6 8.3 55.6 37.1
Campylobacter 56.7 41.7 12.5 13.0 51.9 35.1
EPEC=Enteropathogenic Escherichia coli; ETEC=Enterotoxigenic Escherichia coli
and scores for criterion 4 (maximum disease-re-
duction fraction) were, therefore, correspond-
ingly low. While the aetiologic fractions may vary 
somewhat by region, few pathogens cause more 
than 10% of incident episodes globally, putting a 
practical ceiling on the overall diarrhoeal disease-
burden reduction available by their control even 
with high efficacy and coverage. Further stifling 
the scoring were issues regarding to deliverabil-
ity, and to a lesser extent, equity. 
Water and sanitation
It is somewhat surprising to see the predominantly 
intermediate ranks received by the research options 
that could broadly be categorized as dealing with 
water and sanitation, the theoretical mainstay to 
control the transmission of enteric diseases. Research 
options covered a broad range of issues, includ- 
ing those that deal with quality and quantity of 
water (research option 7, 8, 9, 22, and 23; research 
options addressing the improved disposal of human 
excreta (research option 10, 11, 24, and 44); and 
a single research option addressing handwashing 
(research option 12). As a group, these obtained 
high scores in terms of equity and answerability 
and scores predominantly in the second quartile 
for maximum disease-burden reduction but lower 
scores in other categories, including deliverability 
and sustainability.  
Nutrition
Improving nutritional status has a key role in de-
creasing the burden of diarrhoeal disease. Two of 
the top 10 priority scores, overall, went to research 
options that included zinc, a micronutrient that 
has shown effects in decreasing the duration of di-
arrhoeal episodes and the risk of developing persist-
ent diarrhoea. Increasing the coverage of vitamin 
A supplementation and increasing the energy-den-
sity of weaning foods in areas with food availability 
received priority scores of 71.2% and 67.5% respec-
tively and were in the top quartile of rankings. Re-
search to improve the quality of diet in areas with 
limited food availability obtained a more modest 
priority score of 61.0%. Cash-transfer programmes 
designed to improve diet in areas with restricted ac-
cess were given a priority score of only 47.1% ham-
pered in large part by the perceived problems in 
delivery and maintenance of the programmes.
DISCUSSION
The research options that appear on the list are not 
comprehensive. These are rather meant to be a se-
lection of the top research options representative 
of various strategies of diarrhoeal disease control. 
These include a balance between the development 
of new interventions with research that addresses 
improved implementation of interventions that 
have already been shown to be efficacious. We feel 
that the structured nature of the process of scoring 
research options leads to a significant improve-
ment from previously-used methods involving 
expert consensus. The output is a list of ranking 
options developed by technical experts scoring 
independently to avoid problems associated with 
group dynamics in decision-making. The structure 
of the scoring process minimizes bias through its 
transparency and resulting accountability.  
The prioritization of research options has impor-
tant implications for the assignment of available 
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funds that are intended for the control of diarrhoeal 
disease and the improvement of child health. This 
approach to improve the decision-making process 
has steered away from informal meetings of experts 
that were classically used because of concerns of 
decision-making flaws resulting from both group 
dynamics (i.e. groupthink) (11) and vested interest 
in the development of programmes in the particu-
lar field of interest of the expert. The Delphi proc-
ess was meant to overcome these shortcomings 
through anonymity of scorers, structured feedback, 
and progressive feedback to distill or focus-group 
opinion. However, the Delphi output lacks the 
transparency of the CHNRI process, and the reasons 
behind the scorers’ decisions are unclear. While the 
Delphi thereby works to obtain a consensus, the 
CHNRI process generates a quantitative output 
that allows for the calculation of uncertainty in the 
evaluation of research options through analysis of 
variance of the individual expert’s scores. Further-
more, the CHNRI process elucidates the specific 
contexts within which the priorities are set (prefer-
ably with the investors in health research). It offers 
an approach to systematic listing of large numbers 
of research investment options and comparison 
between options from different research domains 
using the same set of criteria, thus balancing be-
tween high-risk and low-risk options. Its systematic 
nature in scoring research options decreases indi-
vidual bias while independent scoring by many 
experts removes the possibility of a few individuals 
dominating the decisions on priorities.
One of the shortcomings of this scoring exercise 
done at this level and applied to a local level is re-
lated to problems of the context. When scoring is 
done, as was the case here, to be broadly applied 
to the majority of population of the developing 
world, assumptions are made that may not be 
truly representative of certain areas. A key example 
of this relates to issues of deliverability, cost, and 
sustainability. This criterion is the one most likely 
to vary between areas with different levels of po-
litical stability, public infrastructure, and economic 
resources. For these reasons, at the regional level, it 
is worth having a group of experts re-score research 
options for this particular criterion as this may op-
timize the overall evaluation of different research 
options in local contexts. An excel file that facili-
tates this process is available at http://www.icddrb.
org/jhpn.
A second shortcoming of this exercise was the 
limited availability of selected experts for the ex-
ercise. Although 19 experts were invited to partici-
pate, only 10 individuals contributed their priority 
scores. In the future, we would recommend linking 
the scoring activity to a meeting to facilitate higher 
participation rates among appropriate experts.
Despite limitations of the CHNRI process, it has 
several advantages over existing priority-setting 
techniques. First, the transparency of the process in 
and of itself can be a roadmap to researchers and 
potential funding agencies in the area of interest. 
For example, if experts give a low scores for certain 
research option relating to issues surrounding deliv-
erability and equity, researchers in the area will be 
stimulated to develop novel delivery strategies to 
deliver the intervention to those with the greatest 
need, and granting agencies can direct programme 
announcements to fund these proposals. Like the 
Delphi exercise, it controls the influence of group 
dynamics, although it does so to a greater extent 
because scorers are not ‘refocused’ or redirected by 
serial scoring exercises.  
It is clear that the domination of health policy 
and systems research among those obtaining the 
higher ranks is a consequence of results (effects on 
the burden of disease) being expected by 2015. A 
longer timeframe (e.g. 50 years) might allow more 
long-term strategic events to obtain higher scores. 
Furthermore, although the framework for scoring 
is transparent and systematic and it follows that 
rational answers to narrowly-formatted questions 
minimize personal biases, there is a possibility that 
a different group, composed of more policy-makers 
and programme officers rather than the group that 
preformed this exercise, may yield somewhat dif-
ferent results. Despite these limitations, we believe 
that this priority-setting exercise is a useful guide 
to investors in health research targeting diarrhoeal 
disease, who hope to observe measurable results 
prior to the end-date of the millennium develop-
ment goals.
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